Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Robert W Buckingham

Robert W Buckingham

University of Michigan-Flint, USA USA

Elizabeth Secord

Elizabeth Secord

Wayne State University, USA USA

Daniel Bauer

Daniel Bauer

Motivational speaker/ TV artist, HIV escape artist, USA USA

Gary Blick

Gary Blick

World Health Clinicians, USA USA

William Hanna

William Hanna

CY Molecular Diagnostics, Inc., (CYMD), USA USA

Mandy J. Hill

Mandy J. Hill

University of TX Health, USA USA

Arnold Mervyn Levin

Arnold Mervyn Levin

University of the Witwatersrand, South Africa South Africa

Ulrich Desselberger

Ulrich Desselberger

University of Cambridge, UK UK

STD Conference 2019

STD CONFERENCE 2019

Dear Attendees,

Conference Series LLC Ltd proudly announces 7th International Conference on HIV/AIDS, STDs and STIs in March 18-19, 2019 at New York USA. This Conference focus on HIV Science features the latest HIV science, including basic, clinical and prevention research. It brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases.

The primary goals of this activity are to increase each participant's competence to:

  • Summarize current approaches to achieving a cure for HIV infection
  • Identify the optimal antiretroviral management options for patients with HIV and newer therapies in development
  • Illustrate advances in the approach to prevention of HIV infection
  • Recognize factors important for assessing risk for cardiovascular disease and options for preventing cardiovascular morbidities
  • Demonstrate the opportunities and challenges of treating addicted patients
  • Detail the current treatment options for management of patients with HBV or HCV and newer therapies now in development
  • Explain how to recognize, avoid and manage drug-drug interactions
  • Describe developments and controversies in HCV-infected organ transplantation
  • Identifying optimal antiretroviral therapy (ART), treatment initiation, salvage therapy, and pre- and post-exposure prophylaxis and adherence to lifelong therapies

Major Scientific Sessions:

AIDS stigma and discrimination HIV and bone damage
Viral, Bacterial, Fungal & Protozoan STDs HIV and aging
HIV and AIDS Nursing Care Management HIV in women
HIV and Retroviral Diseases Affecting Afro-Asian Continents Global Epidemiology of HIV/AIDS, STDs, & STIs
HIV Drug Discovery and Research HIV Diagnosis and Therapy
Venereal Diseases Prevention and Treatment Emerging Technologies towards HIV/AIDS
HIV and cardiovascular disease HIV/AIDS Related CANCER

 

Market Anlaysis

HIV infection and AIDS have become a major worldwide public health problem. According to WHO approximately 35 million people worldwide living with HIV/AIDS in 2013, unaware of the outcomes. AIDS (acquired immunodeficiency syndrome) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV) which damages the immune system and, interferes with body's ability to fight the organisms that cause disease. HIV is Sexually transmitted diseases which spread by contact with infected blood or from mother to child transmission during pregnancy, childbirth or breast-feeding. It can take years before HIV weakens the immune system to the point that the person is infected with AIDS.

With the generous response and support received from the participants of HIV/AIDS, STDs, & STIs International Conference. Conference Series proudly announces 7th International Conference on HIV/AIDS, STDs and STIs. (STD Conference 2019) which is slated at March 18-19th  New York, USA. The theme of the conference is “Current approaches to achieving a cure for HIV infection”.

Conference Series Organizes 300 Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400 Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. 

Infection rates are high in San Francisco and metro Cities. CA ranked 4th in the number of new AIDS cases, 7th in cumulative AIDS cases and 8th in the number of persons living with AIDS in 50 states, Miami show more than 26,000 people living with HIV/AIDS, and more than 9,500 of these (37%) have diagnosed AIDS cases. Approximately in World 123235 members are associated to HIV/AIDS, 56657 countries wise, 80 city wise. Global HIV/AIDS market, including branded products and generics, was valued at $11.3 billion in 2010.  $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate (CAGR) over the 2011-2016 forecast periods to reach $14.1 billion in 2016. Branded products to treat HIV/AIDS were worth nearly $10.7 billion in 2010 and should reach $11 billion in 2011. This sector is expected to reach $13.2 billion in 2016.For more

 

From the beginning of the epidemic, almost 75 million people have been infected with the HIV virus and about 36 million people have died of HIV. Globally, 35.3 million [32.2–38.8 million] people were living with HIV at the end of 2012. An estimated 0.8% of adults aged 15–49 years worldwide are living with HIV, although the burden of the epidemic continues to vary considerably between countries and regions. Sub-Saharan Africa remains most severely affected, with nearly 1 in every 20 adults living with HIV and accounting for 71% of the people living with HIV worldwide.

Since the height of the epidemic in the mid-1980s, the annual number of new HIV infections in the United States has been reduced by more than two-thirds, from roughly 130,000 to 50,000 annually. Atlanta finds itself the number five ranked city when it comes to new diagnoses of HIV — a statistic that is rooted in HIV testing not being offered in places where most people get access to health care. Grady Hospital is the only emergency department in Atlanta that offers an HIV test to every patient regardless of why they are in need of care. Various universities and research institutes like EMORY university, CDC Atlanta etc performs various research based on HIV/AIDS.

To Collaborate Scientific Professionals around the World

Conference Date March 18-19, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of AIDS & Clinical Research

Journal of HIV & Retro Virus

Journal of Primary & Acquired Immunodeficiency Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner